|
PDSS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.159820E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.545400E-01 |
| Normal-vs-Stage2 |
6.378600E-01 |
| Normal-vs-Stage3 |
1.317780E-02 |
| Normal-vs-Stage4 |
4.626300E-04 |
| Stage1-vs-Stage2 |
2.741200E-01 |
| Stage1-vs-Stage3 |
2.008000E-02 |
| Stage1-vs-Stage4 |
5.980300E-04 |
| Stage2-vs-Stage3 |
7.975600E-03 |
| Stage2-vs-Stage4 |
1.160240E-03 |
| Stage3-vs-Stage4 |
2.171000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.040000E-02 |
| Normal-vs-AfricanAmerican |
6.366200E-01 |
| Normal-vs-Asian |
1.510430E-01 |
| Caucasian-vs-AfricanAmerican |
1.113350E-01 |
| Caucasian-vs-Asian |
9.093800E-01 |
| AfricanAmerican-vs-Asian |
1.328780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.852100E-02 |
| Normal-vs-Female |
2.334000E-01 |
| Male-vs-Female |
1.499800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.707200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.053410E-01 |
| Normal-vs-Age(61-80Yrs) |
1.241360E-01 |
| Normal-vs-Age(81-100Yrs) |
8.642800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.315600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.321200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.431700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.716800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.483900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.055150E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.277400E-03 |
| Classical-VS-Follicular |
1.990240E-01 |
| Classical-VS-Other |
4.814400E-01 |
| Classical-VS-Normal |
1.660420E-01 |
| Tall-VS-Follicular |
9.767100E-04 |
| Tall-VS-Other |
5.943000E-01 |
| Tall-VS-Normal |
8.043900E-04 |
| Follicular-VS-Other |
3.457400E-01 |
| Follicular-VS-Normal |
9.376200E-01 |
| Other-VS-Normal |
1.835370E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.878600E-01 |
| Normal-vs-N1 |
2.985000E-04 |
| N0-vs-N1 |
1.803450E-03 |
|
|
